Enablement – SoCal IP Law Institute

SoCal IP Law Institute MCLE meeting of June 13, 2022 – CAFC re: Intrinsic Evidence on Indefiniteness and Sanctions; and CAFC re: Damages Calculation

Please join us on Monday, June 13, 2022 at 12:00 pm, where we will discuss recent Court of Appeals for the Federal Circuit action regarding Intrinsic Evidence on Indefiniteness and Sanctions; and regarding Damages Calculation For Intrinsic Evidence on Indefiniteness and Sanctions please see: ClearOne v Shure. For Damages Calculation please see: Pavo v. Kingston. [...]

By Angelo Gaz|2022-06-09T19:23:49-07:00March 17th, 2022|Sanctions, Written Description, Attorney's Fees, Damages, Enablement, indefiniteness, Invalidity|0 Comments

SoCal IP MCLE meeting May 10, 2021

Our weekly SoCal IP Institute meeting on Monday, May 10, 2021 will be a discussion of two Federal Circuit cases: Functional Claim “Raises the Bar for Enablement” In Amgen v. Sanofi and Regeneron (Fed. Cir. 2021) (available - Amgen case) the CAFC provided another anti-functional-limitation decision — this time rendering Amgen’s monoclonal antibody claims invalid. [...]

By Angelo Gaz|2021-05-05T17:10:14-07:00May 5th, 2021|Patent, Written Description, Conception, Enablement, indefiniteness, Invalidity, Obviousness|0 Comments

SoCal IP Institute :: July 1, 2013 :: The Line Between Patent and Antitrust &Undue Experimentation Under 35 U.S.C. 112

Our weekly SoCal IP Institute meeting on Monday, July 1, 2013 will be a discussion of a recent Supreme Court case regarding the line between patent and antitrust and a Federal Circuit decision on enablement. Brief synopses of the cases appear below. FTC v. Actavis, Inc., Case No. 12-416 (U.S. June 17, 2013) (available here). [...]

By SoCal IP|2013-06-28T22:01:26-07:00June 28th, 2013|Statutory Subject Matter, Enablement, Antitrust, Patent|0 Comments